Distalmotion SA, a young, international medical device company based in Lausanne, successfully closed its USD 90 million Series E financing round led by Revival Healthcare Capital. Distalmotion is a medical device company founded and based in
Tags :Walder Wyss
XS Participations, a Dutch investment company, has agreed to sell its stake in Twelve Capital Holding, an independent investment manager specializing in investments in the insurance sector, to Graubündner Kantonalbank and management of Twelve
Walder Wyss and Heussen Rechtsanwaltsgesellschaft, Munich, represented client Terra Quantum AG, a Swiss based quantum technology startup company, in its USD 60 million series A financing round. A consortium of certain new and existing investors participated
DDM Group has acquired Swiss Bankers Prepaid Services, the Swiss market leader for prepaid cards. DDM Group, headquartered in Zug, Switzerland, operates as an active investor and partner for financial institutions in Europe including acquisitions
Walder Wyss announced the appointment of Simone Wetzstein and Martin Zobl (both pictured above) as partners in the firm, effective from 1st of January, 2022. Simone Wetzstein is a partner in the Employment Law Team. She
Merck, a global science and technology company, has entered into an agreement to acquire Chord Therapeutics, a Swiss-based biotech company focused on rare neuroinflammatory diseases. With this step, Merck expands its neurology pipeline with the
Existing shareholders, the Infrastructure investor Polhem Infra and the majority shareholder Nordic Infrastructure, acquires all Solör Bioenergy Group shares held by Highview Finance Holding Company DAC. Polhem Infra, wholly owned by the Swedish State
Forterro, a European provider of ERP software solutions to nearly 8,000 midmarket manufacturing and production companies, acquired myfactory, a provider of cloud-based ERP. The acquisition expands Forterro’s total addressable market in DACH, and nearly
So Real Digital Twins, a Swiss company specializing in automating the creation of 3D assets and digital twins, has successfully raised CHF 2.5 Million in a new financing round by conversion of convertible loans into share
Alloy Therapeutics, a Boston based biotechnology ecosystem company, has entered into a definitive agreement to acquire deepCDR Biologics, a privately held Basel based developer of deep learning technology for antibody discovery and optimisation. Alloy will
